Dapagliflozin and Silymarin Ameliorate Cisplatin-Induced Nephrotoxicity via Nrf2/HO-1 Upregulation: A Preclinical Mechanistic Study

Dapagliflozin and Silymarin Ameliorate Cisplatin-Induced Nephrotoxicity via Nrf2/HO-1 Upregulation: A Preclinical Mechanistic Study

This study evaluated the nephroprotective potential of dapagliflozin and silymarin, alone and in combination, against cisplatin-induced kidney damage in female Wistar rats. Cisplatin was administered at 3 mg/kg weekly to all groups except the normal controls, with treatments of silymarin (50 mg/kg/d...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shakta Mani Satyam, Laxminarayana Kurady Bairy, Abdul Rehman, Anuradha Asokan Nair, Mohamed Farook, Nirmal Nachiketh Binu, Sofiya Khan, Mohamed Yehya, Mohammed Moin Khan
Format:	Article
Language:	English
Published:	MDPI AG 2025-05-01
Series:	Sci
Subjects:	sodium-glucose transporter protein-2 inhibitors chemotherapy chemo protectant cancer chronic kidney disease repurposing drugs
Online Access:	https://www.mdpi.com/2413-4155/7/2/59
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

BENEFICIAL EFFECTS OF SILYMARIN AGAINST NEPHROTOXICITY CAUSED BY SOME CHEMICALS
by: V. Ivanov, et al.
Published: (2021-06-01)

Efficacy of nanodiamond–doxorubicin complexes on human breast adenocarcinoma cell lines
by: Kitsakorn Locharoenrat
Published: (2019-12-01)

LOCAL HYPERTHERMIA IN THE COMBINED TREATMENT OF LOCALLY ADVANCED SOFT TISSUE SARCOMAS
by: A. L. Zubarev, et al.
Published: (2016-02-01)

Silymarin and Vanillic Acid Silver Nanoparticles Alleviate the Carbon Tetrachloride-Induced Nephrotoxicity in Male Rats
by: Haddad A. El Rabey, et al.
Published: (2023-01-01)

Analysis of operability parameter changes in neoadjuvant treatment with chemotherapy and anti-PD-1/PD-L1
by: M Sereno, et al.
Published: (2025-01-01)

Chitosan-MXene-gold-curcumin: quaternary nanohybrid platform: A Chemo/Photothermal onco-strategy for improved cancer therapy
by: Nihal Saad Elbialy, et al.
Published: (2025-06-01)

VARIANTS AND PERSPECTIVES OF DRUG REPURPOSING FOR CANCER TREATMENT
by: A. V. Savinkova, et al.
Published: (2018-07-01)

Combination chemotherapy and hormone therapy in patients with hormone receptor positive and HER2 negative metastatic breast cancer
by: Kripa Bajaj, et al.
Published: (2025-08-01)

Targeting cytokine and chemokine signaling pathways for enhancing chemo-sensitivity in colorectal cancer
by: Shisen Li, et al.
Published: (2025-08-01)

Spectrum of chemo-radiotherapy induced fungal infection in head and neck cancer patients at tertiary care centre of Eastern India
by: Vidyut Prakash, et al.
Published: (2023-06-01)

PENGGUNAAN MEDIA SIRKUIT CERDIK BERBASIS CHEMO-EDUTAINMENT DALAM PEMBELAJARAN LARUTAN ASAM BASA
by: S. Priatmoko, et al.
Published: (2012-04-01)

Repurposing Anthelmintic Drugs for COVID-19 Treatment: A Comprehensive Meta-Analysis of Randomized Clinical Trials on Ivermectin and Mebendazole
by: Shakta Mani Satyam, et al.
Published: (2025-04-01)

Nephroprotective Roles of L-Cysteine, Silymarin and Ursodeoxycholic acid, against Carbon Tetrachloride induced Nephrotoxicity in Male Albino Rats
by: Hero H. Muhammed Saed Mrs, et al.
Published: (2023-09-01)

The effectiveness of endobronchial therapy in patients with chemo-resistant tuberculosis when specific process is localized in the lungs apical segments
by: V. M. Khlystun
Published: (2017-08-01)

In vitro regeneration and phytochemical evaluation of pippali (Piper longum) for conservation and therapeutic applications
by: ARIJITA MOHANTY, et al.
Published: (2025-03-01)

Chemo-sorption nonwoven textile materials for purification of waste waters containing Cu**
by: Margarita Neznakomova, et al.
Published: (2016-03-01)

Mucins as Precision Biomarkers in Glioma: Emerging Evidence for Their Potential in Biospecimen Analysis and Outcome Prediction
by: Anna Erickson, et al.
Published: (2024-12-01)

Chemo-selective modification of cysteine residue: synthesis and application in the discovery of potential drug candidates
by: Yanyan Liao, et al.
Published: (2024-09-01)

Clinical Management in NSCLC Patients With EGFR Mutation After Osimertinib Progression With Unknown Resistance Mechanisms
by: Xin Liao, et al.
Published: (2024-10-01)

The Effect of Dapagliflozin, a Sodium–Glucose Co-Transporter 2 Inhibitor, on Vancomycin-Induced Nephrotoxicity in Rats
by: Seyhmus Tan, et al.
Published: (2025-06-01)

Upscaling Lithium-ion Batteries for Small Scale Applications
by: Vanishree Sah P., et al.
Published: (2025-01-01)

Novel synergistic antibacterial activity of meloxicam-curcumin and diclofenac-curcumin combinations against methicillin-sensitive S. aureus and E. faecium
by: Asem M. Karajeh, et al.
Published: (2025-02-01)

Pseudohypoxia-Stabilized HIF2α Transcriptionally Inhibits <i>MNRR1</i>, a Druggable Target in MELAS
by: Neeraja Purandare, et al.
Published: (2025-07-01)

Drug repurposing: Clinical practices and regulatory pathways
by: K. Saranraj, et al.
Published: (2025-04-01)

Repurposing piroxicam enhances the antineoplastic effects of docetaxel and enzalutamide in prostate cancer cells using 2D and 3D in vitro culture models
by: Amani Yehya, et al.
Published: (2025-07-01)

Intramuscular Botulinum Neurotoxin Injections for Infantile Esotropia: A Durban Academic Hospital Review
by: Mohammed Khan, et al.
Published: (2025-02-01)

Short term outcomes of robotic surgery after neoadjuvant treatment for locally advanced NSCLC: a comparison with the open approach
by: Filippo Tommaso Gallina, et al.
Published: (2025-08-01)

The Use of Ibrutinib in Refractory Chronic Lymphocytic Leukemia and in High-Risk Patients
by: NV Kurkina, et al.
Published: (2019-05-01)

Engineered biomimetic cisplatin-polyphenol nanocomplex for chemo-immunotherapy of glioblastoma by inducing pyroptosis
by: Xinyan Hao, et al.
Published: (2025-01-01)

Ameliorative Protective Influence of Etoricoxib Against Chemo Convulsions Correlates with Blood Glucose Levels in Rats
by: S. Aparna, et al.
Published: (2024-07-01)

Bevacizumab is associated with delayed anastomotic leak after low anterior resection with preoperative radiotherapy for rectal cancer: a case report
by: Erika Machida, et al.
Published: (2019-01-01)

Cetuximab-Taxanes-Platinum-Fluorouracil/Capecitabine (C-TPF/C-TPX) – a Feasible Option for Recurrent HNSCC with Negative Prognostic Factors. Literature Review with a Case Presentation
by: Camil Ciprian MIRESTEAN, et al.
Published: (2023-03-01)

Modulation of Brain Kynurenic Acid by N-Acetylcysteine Prevents Cognitive Impairment and Muscular Weakness Induced by Cisplatin in Female Rats
by: Teminijesu Dorcas Aremu, et al.
Published: (2024-12-01)

A Review on Analytical Techniques for Quantitative Detection of Biogenic Amines in Aquatic Products
by: Zixin Chen, et al.
Published: (2024-12-01)

Literature data-based de novo candidates for drug repurposing
by: Xianglong Liang, et al.
Published: (2025-08-01)

Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design
by: Lisa Daniel-Fischer, et al.
Published: (2024-02-01)

Pilocarpine inhibits Candida albicans SC5314 biofilm maturation by altering lipid, sphingolipid, and protein content
by: Emerenziana Ottaviano, et al.
Published: (2025-05-01)

Informative integration of modern spolia in public landscapes
by: Deniz Üçer Erduran
Published: (2025-03-01)

Research and pilot analysis of bevacizumab repurposing potential and its impact in clinical practice
by: Antonio Ivanov, et al.
Published: (2024-12-01)

Phytochemical characterization and bioinformatics guided evaluation of antioxidant and cytotoxic effects of Psoralea bituminosa
by: Nour H. Aboalhaija, et al.
Published: (2025-05-01)